Global Glucagon Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Glucagon. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Glucagon market.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
Key Features:
The report on Glucagon market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Glucagon market. It may include historical data, market segmentation by Type (e.g., Inject Glucagon, Nasal Glucagon), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Glucagon market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Glucagon market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Glucagon industry. This include advancements in Glucagon technology, Glucagon new entrants, Glucagon new investment, and other innovations that are shaping the future of Glucagon.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Glucagon market. It includes factors influencing customer ' purchasing decisions, preferences for Glucagon product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Glucagon market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Glucagon market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Glucagon market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Glucagon industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Glucagon market.
Market Segmentation:
Glucagon market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Glucagon market?
What factors are driving Glucagon market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glucagon market opportunities vary by end market size?
How does Glucagon break out type, application?
According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Glucagon. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Glucagon market.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
Key Features:
The report on Glucagon market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Glucagon market. It may include historical data, market segmentation by Type (e.g., Inject Glucagon, Nasal Glucagon), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Glucagon market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Glucagon market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Glucagon industry. This include advancements in Glucagon technology, Glucagon new entrants, Glucagon new investment, and other innovations that are shaping the future of Glucagon.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Glucagon market. It includes factors influencing customer ' purchasing decisions, preferences for Glucagon product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Glucagon market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Glucagon market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Glucagon market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Glucagon industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Glucagon market.
Market Segmentation:
Glucagon market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Inject Glucagon
- Nasal Glucagon
- Emergency Kits
- General Use
- Diagnostic & Motility
- Cardiogenic Shock
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Eli Lilly
- Fresenius Kabi
- Torrent Labs
- Taj Pharmaceuticals
- Xeris Pharmaceuticals
What is the 10-year outlook for the global Glucagon market?
What factors are driving Glucagon market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glucagon market opportunities vary by end market size?
How does Glucagon break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Glucagon Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Glucagon by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Glucagon by Country/Region, 2019, 2023 & 2030
2.2 Glucagon Segment by Type
2.2.1 Inject Glucagon
2.2.2 Nasal Glucagon
2.3 Glucagon Sales by Type
2.3.1 Global Glucagon Sales Market Share by Type (2019-2024)
2.3.2 Global Glucagon Revenue and Market Share by Type (2019-2024)
2.3.3 Global Glucagon Sale Price by Type (2019-2024)
2.4 Glucagon Segment by Application
2.4.1 Emergency Kits
2.4.2 General Use
2.4.3 Diagnostic & Motility
2.4.4 Cardiogenic Shock
2.4.5 Others
2.5 Glucagon Sales by Application
2.5.1 Global Glucagon Sale Market Share by Application (2019-2024)
2.5.2 Global Glucagon Revenue and Market Share by Application (2019-2024)
2.5.3 Global Glucagon Sale Price by Application (2019-2024)
3 GLOBAL GLUCAGON BY COMPANY
3.1 Global Glucagon Breakdown Data by Company
3.1.1 Global Glucagon Annual Sales by Company (2019-2024)
3.1.2 Global Glucagon Sales Market Share by Company (2019-2024)
3.2 Global Glucagon Annual Revenue by Company (2019-2024)
3.2.1 Global Glucagon Revenue by Company (2019-2024)
3.2.2 Global Glucagon Revenue Market Share by Company (2019-2024)
3.3 Global Glucagon Sale Price by Company
3.4 Key Manufacturers Glucagon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glucagon Product Location Distribution
3.4.2 Players Glucagon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GLUCAGON BY GEOGRAPHIC REGION
4.1 World Historic Glucagon Market Size by Geographic Region (2019-2024)
4.1.1 Global Glucagon Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Glucagon Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Glucagon Market Size by Country/Region (2019-2024)
4.2.1 Global Glucagon Annual Sales by Country/Region (2019-2024)
4.2.2 Global Glucagon Annual Revenue by Country/Region (2019-2024)
4.3 Americas Glucagon Sales Growth
4.4 APAC Glucagon Sales Growth
4.5 Europe Glucagon Sales Growth
4.6 Middle East & Africa Glucagon Sales Growth
5 AMERICAS
5.1 Americas Glucagon Sales by Country
5.1.1 Americas Glucagon Sales by Country (2019-2024)
5.1.2 Americas Glucagon Revenue by Country (2019-2024)
5.2 Americas Glucagon Sales by Type
5.3 Americas Glucagon Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glucagon Sales by Region
6.1.1 APAC Glucagon Sales by Region (2019-2024)
6.1.2 APAC Glucagon Revenue by Region (2019-2024)
6.2 APAC Glucagon Sales by Type
6.3 APAC Glucagon Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Glucagon by Country
7.1.1 Europe Glucagon Sales by Country (2019-2024)
7.1.2 Europe Glucagon Revenue by Country (2019-2024)
7.2 Europe Glucagon Sales by Type
7.3 Europe Glucagon Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Glucagon by Country
8.1.1 Middle East & Africa Glucagon Sales by Country (2019-2024)
8.1.2 Middle East & Africa Glucagon Revenue by Country (2019-2024)
8.2 Middle East & Africa Glucagon Sales by Type
8.3 Middle East & Africa Glucagon Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glucagon
10.3 Manufacturing Process Analysis of Glucagon
10.4 Industry Chain Structure of Glucagon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glucagon Distributors
11.3 Glucagon Customer
12 WORLD FORECAST REVIEW FOR GLUCAGON BY GEOGRAPHIC REGION
12.1 Global Glucagon Market Size Forecast by Region
12.1.1 Global Glucagon Forecast by Region (2025-2030)
12.1.2 Global Glucagon Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glucagon Forecast by Type
12.7 Global Glucagon Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Glucagon Product Portfolios and Specifications
13.1.3 Novo Nordisk Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly Glucagon Product Portfolios and Specifications
13.2.3 Eli Lilly Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi Glucagon Product Portfolios and Specifications
13.3.3 Fresenius Kabi Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Torrent Labs
13.4.1 Torrent Labs Company Information
13.4.2 Torrent Labs Glucagon Product Portfolios and Specifications
13.4.3 Torrent Labs Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Torrent Labs Main Business Overview
13.4.5 Torrent Labs Latest Developments
13.5 Taj Pharmaceuticals
13.5.1 Taj Pharmaceuticals Company Information
13.5.2 Taj Pharmaceuticals Glucagon Product Portfolios and Specifications
13.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Taj Pharmaceuticals Main Business Overview
13.5.5 Taj Pharmaceuticals Latest Developments
13.6 Xeris Pharmaceuticals
13.6.1 Xeris Pharmaceuticals Company Information
13.6.2 Xeris Pharmaceuticals Glucagon Product Portfolios and Specifications
13.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Xeris Pharmaceuticals Main Business Overview
13.6.5 Xeris Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Glucagon Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Glucagon by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Glucagon by Country/Region, 2019, 2023 & 2030
2.2 Glucagon Segment by Type
2.2.1 Inject Glucagon
2.2.2 Nasal Glucagon
2.3 Glucagon Sales by Type
2.3.1 Global Glucagon Sales Market Share by Type (2019-2024)
2.3.2 Global Glucagon Revenue and Market Share by Type (2019-2024)
2.3.3 Global Glucagon Sale Price by Type (2019-2024)
2.4 Glucagon Segment by Application
2.4.1 Emergency Kits
2.4.2 General Use
2.4.3 Diagnostic & Motility
2.4.4 Cardiogenic Shock
2.4.5 Others
2.5 Glucagon Sales by Application
2.5.1 Global Glucagon Sale Market Share by Application (2019-2024)
2.5.2 Global Glucagon Revenue and Market Share by Application (2019-2024)
2.5.3 Global Glucagon Sale Price by Application (2019-2024)
3 GLOBAL GLUCAGON BY COMPANY
3.1 Global Glucagon Breakdown Data by Company
3.1.1 Global Glucagon Annual Sales by Company (2019-2024)
3.1.2 Global Glucagon Sales Market Share by Company (2019-2024)
3.2 Global Glucagon Annual Revenue by Company (2019-2024)
3.2.1 Global Glucagon Revenue by Company (2019-2024)
3.2.2 Global Glucagon Revenue Market Share by Company (2019-2024)
3.3 Global Glucagon Sale Price by Company
3.4 Key Manufacturers Glucagon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glucagon Product Location Distribution
3.4.2 Players Glucagon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GLUCAGON BY GEOGRAPHIC REGION
4.1 World Historic Glucagon Market Size by Geographic Region (2019-2024)
4.1.1 Global Glucagon Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Glucagon Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Glucagon Market Size by Country/Region (2019-2024)
4.2.1 Global Glucagon Annual Sales by Country/Region (2019-2024)
4.2.2 Global Glucagon Annual Revenue by Country/Region (2019-2024)
4.3 Americas Glucagon Sales Growth
4.4 APAC Glucagon Sales Growth
4.5 Europe Glucagon Sales Growth
4.6 Middle East & Africa Glucagon Sales Growth
5 AMERICAS
5.1 Americas Glucagon Sales by Country
5.1.1 Americas Glucagon Sales by Country (2019-2024)
5.1.2 Americas Glucagon Revenue by Country (2019-2024)
5.2 Americas Glucagon Sales by Type
5.3 Americas Glucagon Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glucagon Sales by Region
6.1.1 APAC Glucagon Sales by Region (2019-2024)
6.1.2 APAC Glucagon Revenue by Region (2019-2024)
6.2 APAC Glucagon Sales by Type
6.3 APAC Glucagon Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Glucagon by Country
7.1.1 Europe Glucagon Sales by Country (2019-2024)
7.1.2 Europe Glucagon Revenue by Country (2019-2024)
7.2 Europe Glucagon Sales by Type
7.3 Europe Glucagon Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Glucagon by Country
8.1.1 Middle East & Africa Glucagon Sales by Country (2019-2024)
8.1.2 Middle East & Africa Glucagon Revenue by Country (2019-2024)
8.2 Middle East & Africa Glucagon Sales by Type
8.3 Middle East & Africa Glucagon Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glucagon
10.3 Manufacturing Process Analysis of Glucagon
10.4 Industry Chain Structure of Glucagon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glucagon Distributors
11.3 Glucagon Customer
12 WORLD FORECAST REVIEW FOR GLUCAGON BY GEOGRAPHIC REGION
12.1 Global Glucagon Market Size Forecast by Region
12.1.1 Global Glucagon Forecast by Region (2025-2030)
12.1.2 Global Glucagon Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glucagon Forecast by Type
12.7 Global Glucagon Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Glucagon Product Portfolios and Specifications
13.1.3 Novo Nordisk Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly Glucagon Product Portfolios and Specifications
13.2.3 Eli Lilly Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi Glucagon Product Portfolios and Specifications
13.3.3 Fresenius Kabi Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Torrent Labs
13.4.1 Torrent Labs Company Information
13.4.2 Torrent Labs Glucagon Product Portfolios and Specifications
13.4.3 Torrent Labs Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Torrent Labs Main Business Overview
13.4.5 Torrent Labs Latest Developments
13.5 Taj Pharmaceuticals
13.5.1 Taj Pharmaceuticals Company Information
13.5.2 Taj Pharmaceuticals Glucagon Product Portfolios and Specifications
13.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Taj Pharmaceuticals Main Business Overview
13.5.5 Taj Pharmaceuticals Latest Developments
13.6 Xeris Pharmaceuticals
13.6.1 Xeris Pharmaceuticals Company Information
13.6.2 Xeris Pharmaceuticals Glucagon Product Portfolios and Specifications
13.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Xeris Pharmaceuticals Main Business Overview
13.6.5 Xeris Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Glucagon Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Glucagon Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Inject Glucagon
Table 4. Major Players of Nasal Glucagon
Table 5. Global Glucagon Sales by Type (2019-2024) & (K MT)
Table 6. Global Glucagon Sales Market Share by Type (2019-2024)
Table 7. Global Glucagon Revenue by Type (2019-2024) & ($ million)
Table 8. Global Glucagon Revenue Market Share by Type (2019-2024)
Table 9. Global Glucagon Sale Price by Type (2019-2024) & (USD/MT)
Table 10. Global Glucagon Sales by Application (2019-2024) & (K MT)
Table 11. Global Glucagon Sales Market Share by Application (2019-2024)
Table 12. Global Glucagon Revenue by Application (2019-2024)
Table 13. Global Glucagon Revenue Market Share by Application (2019-2024)
Table 14. Global Glucagon Sale Price by Application (2019-2024) & (USD/MT)
Table 15. Global Glucagon Sales by Company (2019-2024) & (K MT)
Table 16. Global Glucagon Sales Market Share by Company (2019-2024)
Table 17. Global Glucagon Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Glucagon Revenue Market Share by Company (2019-2024)
Table 19. Global Glucagon Sale Price by Company (2019-2024) & (USD/MT)
Table 20. Key Manufacturers Glucagon Producing Area Distribution and Sales Area
Table 21. Players Glucagon Products Offered
Table 22. Glucagon Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Glucagon Sales by Geographic Region (2019-2024) & (K MT)
Table 26. Global Glucagon Sales Market Share Geographic Region (2019-2024)
Table 27. Global Glucagon Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Glucagon Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Glucagon Sales by Country/Region (2019-2024) & (K MT)
Table 30. Global Glucagon Sales Market Share by Country/Region (2019-2024)
Table 31. Global Glucagon Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Glucagon Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Glucagon Sales by Country (2019-2024) & (K MT)
Table 34. Americas Glucagon Sales Market Share by Country (2019-2024)
Table 35. Americas Glucagon Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Glucagon Revenue Market Share by Country (2019-2024)
Table 37. Americas Glucagon Sales by Type (2019-2024) & (K MT)
Table 38. Americas Glucagon Sales by Application (2019-2024) & (K MT)
Table 39. APAC Glucagon Sales by Region (2019-2024) & (K MT)
Table 40. APAC Glucagon Sales Market Share by Region (2019-2024)
Table 41. APAC Glucagon Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Glucagon Revenue Market Share by Region (2019-2024)
Table 43. APAC Glucagon Sales by Type (2019-2024) & (K MT)
Table 44. APAC Glucagon Sales by Application (2019-2024) & (K MT)
Table 45. Europe Glucagon Sales by Country (2019-2024) & (K MT)
Table 46. Europe Glucagon Sales Market Share by Country (2019-2024)
Table 47. Europe Glucagon Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Glucagon Revenue Market Share by Country (2019-2024)
Table 49. Europe Glucagon Sales by Type (2019-2024) & (K MT)
Table 50. Europe Glucagon Sales by Application (2019-2024) & (K MT)
Table 51. Middle East & Africa Glucagon Sales by Country (2019-2024) & (K MT)
Table 52. Middle East & Africa Glucagon Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Glucagon Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Glucagon Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Glucagon Sales by Type (2019-2024) & (K MT)
Table 56. Middle East & Africa Glucagon Sales by Application (2019-2024) & (K MT)
Table 57. Key Market Drivers & Growth Opportunities of Glucagon
Table 58. Key Market Challenges & Risks of Glucagon
Table 59. Key Industry Trends of Glucagon
Table 60. Glucagon Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Glucagon Distributors List
Table 63. Glucagon Customer List
Table 64. Global Glucagon Sales Forecast by Region (2025-2030) & (K MT)
Table 65. Global Glucagon Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Glucagon Sales Forecast by Country (2025-2030) & (K MT)
Table 67. Americas Glucagon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Glucagon Sales Forecast by Region (2025-2030) & (K MT)
Table 69. APAC Glucagon Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Glucagon Sales Forecast by Country (2025-2030) & (K MT)
Table 71. Europe Glucagon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Glucagon Sales Forecast by Country (2025-2030) & (K MT)
Table 73. Middle East & Africa Glucagon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Glucagon Sales Forecast by Type (2025-2030) & (K MT)
Table 75. Global Glucagon Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Glucagon Sales Forecast by Application (2025-2030) & (K MT)
Table 77. Global Glucagon Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Novo Nordisk Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 79. Novo Nordisk Glucagon Product Portfolios and Specifications
Table 80. Novo Nordisk Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. Eli Lilly Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly Glucagon Product Portfolios and Specifications
Table 85. Eli Lilly Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. Fresenius Kabi Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 89. Fresenius Kabi Glucagon Product Portfolios and Specifications
Table 90. Fresenius Kabi Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 91. Fresenius Kabi Main Business
Table 92. Fresenius Kabi Latest Developments
Table 93. Torrent Labs Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 94. Torrent Labs Glucagon Product Portfolios and Specifications
Table 95. Torrent Labs Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 96. Torrent Labs Main Business
Table 97. Torrent Labs Latest Developments
Table 98. Taj Pharmaceuticals Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 99. Taj Pharmaceuticals Glucagon Product Portfolios and Specifications
Table 100. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 101. Taj Pharmaceuticals Main Business
Table 102. Taj Pharmaceuticals Latest Developments
Table 103. Xeris Pharmaceuticals Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 104. Xeris Pharmaceuticals Glucagon Product Portfolios and Specifications
Table 105. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 106. Xeris Pharmaceuticals Main Business
Table 107. Xeris Pharmaceuticals Latest Developments
Table 1. Glucagon Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Glucagon Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Inject Glucagon
Table 4. Major Players of Nasal Glucagon
Table 5. Global Glucagon Sales by Type (2019-2024) & (K MT)
Table 6. Global Glucagon Sales Market Share by Type (2019-2024)
Table 7. Global Glucagon Revenue by Type (2019-2024) & ($ million)
Table 8. Global Glucagon Revenue Market Share by Type (2019-2024)
Table 9. Global Glucagon Sale Price by Type (2019-2024) & (USD/MT)
Table 10. Global Glucagon Sales by Application (2019-2024) & (K MT)
Table 11. Global Glucagon Sales Market Share by Application (2019-2024)
Table 12. Global Glucagon Revenue by Application (2019-2024)
Table 13. Global Glucagon Revenue Market Share by Application (2019-2024)
Table 14. Global Glucagon Sale Price by Application (2019-2024) & (USD/MT)
Table 15. Global Glucagon Sales by Company (2019-2024) & (K MT)
Table 16. Global Glucagon Sales Market Share by Company (2019-2024)
Table 17. Global Glucagon Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Glucagon Revenue Market Share by Company (2019-2024)
Table 19. Global Glucagon Sale Price by Company (2019-2024) & (USD/MT)
Table 20. Key Manufacturers Glucagon Producing Area Distribution and Sales Area
Table 21. Players Glucagon Products Offered
Table 22. Glucagon Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Glucagon Sales by Geographic Region (2019-2024) & (K MT)
Table 26. Global Glucagon Sales Market Share Geographic Region (2019-2024)
Table 27. Global Glucagon Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Glucagon Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Glucagon Sales by Country/Region (2019-2024) & (K MT)
Table 30. Global Glucagon Sales Market Share by Country/Region (2019-2024)
Table 31. Global Glucagon Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Glucagon Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Glucagon Sales by Country (2019-2024) & (K MT)
Table 34. Americas Glucagon Sales Market Share by Country (2019-2024)
Table 35. Americas Glucagon Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Glucagon Revenue Market Share by Country (2019-2024)
Table 37. Americas Glucagon Sales by Type (2019-2024) & (K MT)
Table 38. Americas Glucagon Sales by Application (2019-2024) & (K MT)
Table 39. APAC Glucagon Sales by Region (2019-2024) & (K MT)
Table 40. APAC Glucagon Sales Market Share by Region (2019-2024)
Table 41. APAC Glucagon Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Glucagon Revenue Market Share by Region (2019-2024)
Table 43. APAC Glucagon Sales by Type (2019-2024) & (K MT)
Table 44. APAC Glucagon Sales by Application (2019-2024) & (K MT)
Table 45. Europe Glucagon Sales by Country (2019-2024) & (K MT)
Table 46. Europe Glucagon Sales Market Share by Country (2019-2024)
Table 47. Europe Glucagon Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Glucagon Revenue Market Share by Country (2019-2024)
Table 49. Europe Glucagon Sales by Type (2019-2024) & (K MT)
Table 50. Europe Glucagon Sales by Application (2019-2024) & (K MT)
Table 51. Middle East & Africa Glucagon Sales by Country (2019-2024) & (K MT)
Table 52. Middle East & Africa Glucagon Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Glucagon Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Glucagon Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Glucagon Sales by Type (2019-2024) & (K MT)
Table 56. Middle East & Africa Glucagon Sales by Application (2019-2024) & (K MT)
Table 57. Key Market Drivers & Growth Opportunities of Glucagon
Table 58. Key Market Challenges & Risks of Glucagon
Table 59. Key Industry Trends of Glucagon
Table 60. Glucagon Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Glucagon Distributors List
Table 63. Glucagon Customer List
Table 64. Global Glucagon Sales Forecast by Region (2025-2030) & (K MT)
Table 65. Global Glucagon Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Glucagon Sales Forecast by Country (2025-2030) & (K MT)
Table 67. Americas Glucagon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Glucagon Sales Forecast by Region (2025-2030) & (K MT)
Table 69. APAC Glucagon Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Glucagon Sales Forecast by Country (2025-2030) & (K MT)
Table 71. Europe Glucagon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Glucagon Sales Forecast by Country (2025-2030) & (K MT)
Table 73. Middle East & Africa Glucagon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Glucagon Sales Forecast by Type (2025-2030) & (K MT)
Table 75. Global Glucagon Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Glucagon Sales Forecast by Application (2025-2030) & (K MT)
Table 77. Global Glucagon Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Novo Nordisk Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 79. Novo Nordisk Glucagon Product Portfolios and Specifications
Table 80. Novo Nordisk Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. Eli Lilly Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly Glucagon Product Portfolios and Specifications
Table 85. Eli Lilly Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. Fresenius Kabi Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 89. Fresenius Kabi Glucagon Product Portfolios and Specifications
Table 90. Fresenius Kabi Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 91. Fresenius Kabi Main Business
Table 92. Fresenius Kabi Latest Developments
Table 93. Torrent Labs Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 94. Torrent Labs Glucagon Product Portfolios and Specifications
Table 95. Torrent Labs Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 96. Torrent Labs Main Business
Table 97. Torrent Labs Latest Developments
Table 98. Taj Pharmaceuticals Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 99. Taj Pharmaceuticals Glucagon Product Portfolios and Specifications
Table 100. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 101. Taj Pharmaceuticals Main Business
Table 102. Taj Pharmaceuticals Latest Developments
Table 103. Xeris Pharmaceuticals Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 104. Xeris Pharmaceuticals Glucagon Product Portfolios and Specifications
Table 105. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 106. Xeris Pharmaceuticals Main Business
Table 107. Xeris Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Glucagon
Figure 2. Glucagon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glucagon Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Glucagon Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Glucagon Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Inject Glucagon
Figure 10. Product Picture of Nasal Glucagon
Figure 11. Global Glucagon Sales Market Share by Type in 2023
Figure 12. Global Glucagon Revenue Market Share by Type (2019-2024)
Figure 13. Glucagon Consumed in Emergency Kits
Figure 14. Global Glucagon Market: Emergency Kits (2019-2024) & (K MT)
Figure 15. Glucagon Consumed in General Use
Figure 16. Global Glucagon Market: General Use (2019-2024) & (K MT)
Figure 17. Glucagon Consumed in Diagnostic & Motility
Figure 18. Global Glucagon Market: Diagnostic & Motility (2019-2024) & (K MT)
Figure 19. Glucagon Consumed in Cardiogenic Shock
Figure 20. Global Glucagon Market: Cardiogenic Shock (2019-2024) & (K MT)
Figure 21. Glucagon Consumed in Others
Figure 22. Global Glucagon Market: Others (2019-2024) & (K MT)
Figure 23. Global Glucagon Sales Market Share by Application (2023)
Figure 24. Global Glucagon Revenue Market Share by Application in 2023
Figure 25. Glucagon Sales Market by Company in 2023 (K MT)
Figure 26. Global Glucagon Sales Market Share by Company in 2023
Figure 27. Glucagon Revenue Market by Company in 2023 ($ Million)
Figure 28. Global Glucagon Revenue Market Share by Company in 2023
Figure 29. Global Glucagon Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Glucagon Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Glucagon Sales 2019-2024 (K MT)
Figure 32. Americas Glucagon Revenue 2019-2024 ($ Millions)
Figure 33. APAC Glucagon Sales 2019-2024 (K MT)
Figure 34. APAC Glucagon Revenue 2019-2024 ($ Millions)
Figure 35. Europe Glucagon Sales 2019-2024 (K MT)
Figure 36. Europe Glucagon Revenue 2019-2024 ($ Millions)
Figure 37. Middle East & Africa Glucagon Sales 2019-2024 (K MT)
Figure 38. Middle East & Africa Glucagon Revenue 2019-2024 ($ Millions)
Figure 39. Americas Glucagon Sales Market Share by Country in 2023
Figure 40. Americas Glucagon Revenue Market Share by Country in 2023
Figure 41. Americas Glucagon Sales Market Share by Type (2019-2024)
Figure 42. Americas Glucagon Sales Market Share by Application (2019-2024)
Figure 43. United States Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 44. Canada Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 45. Mexico Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 46. Brazil Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 47. APAC Glucagon Sales Market Share by Region in 2023
Figure 48. APAC Glucagon Revenue Market Share by Regions in 2023
Figure 49. APAC Glucagon Sales Market Share by Type (2019-2024)
Figure 50. APAC Glucagon Sales Market Share by Application (2019-2024)
Figure 51. China Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 52. Japan Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 53. South Korea Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 54. Southeast Asia Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 55. India Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 56. Australia Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 57. China Taiwan Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 58. Europe Glucagon Sales Market Share by Country in 2023
Figure 59. Europe Glucagon Revenue Market Share by Country in 2023
Figure 60. Europe Glucagon Sales Market Share by Type (2019-2024)
Figure 61. Europe Glucagon Sales Market Share by Application (2019-2024)
Figure 62. Germany Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 63. France Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 64. UK Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 65. Italy Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 66. Russia Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 67. Middle East & Africa Glucagon Sales Market Share by Country in 2023
Figure 68. Middle East & Africa Glucagon Revenue Market Share by Country in 2023
Figure 69. Middle East & Africa Glucagon Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Glucagon Sales Market Share by Application (2019-2024)
Figure 71. Egypt Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 72. South Africa Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 73. Israel Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 74. Turkey Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 75. GCC Country Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Glucagon in 2023
Figure 77. Manufacturing Process Analysis of Glucagon
Figure 78. Industry Chain Structure of Glucagon
Figure 79. Channels of Distribution
Figure 80. Global Glucagon Sales Market Forecast by Region (2025-2030)
Figure 81. Global Glucagon Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Glucagon Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Glucagon Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Glucagon Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Glucagon Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Glucagon
Figure 2. Glucagon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glucagon Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Glucagon Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Glucagon Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Inject Glucagon
Figure 10. Product Picture of Nasal Glucagon
Figure 11. Global Glucagon Sales Market Share by Type in 2023
Figure 12. Global Glucagon Revenue Market Share by Type (2019-2024)
Figure 13. Glucagon Consumed in Emergency Kits
Figure 14. Global Glucagon Market: Emergency Kits (2019-2024) & (K MT)
Figure 15. Glucagon Consumed in General Use
Figure 16. Global Glucagon Market: General Use (2019-2024) & (K MT)
Figure 17. Glucagon Consumed in Diagnostic & Motility
Figure 18. Global Glucagon Market: Diagnostic & Motility (2019-2024) & (K MT)
Figure 19. Glucagon Consumed in Cardiogenic Shock
Figure 20. Global Glucagon Market: Cardiogenic Shock (2019-2024) & (K MT)
Figure 21. Glucagon Consumed in Others
Figure 22. Global Glucagon Market: Others (2019-2024) & (K MT)
Figure 23. Global Glucagon Sales Market Share by Application (2023)
Figure 24. Global Glucagon Revenue Market Share by Application in 2023
Figure 25. Glucagon Sales Market by Company in 2023 (K MT)
Figure 26. Global Glucagon Sales Market Share by Company in 2023
Figure 27. Glucagon Revenue Market by Company in 2023 ($ Million)
Figure 28. Global Glucagon Revenue Market Share by Company in 2023
Figure 29. Global Glucagon Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Glucagon Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Glucagon Sales 2019-2024 (K MT)
Figure 32. Americas Glucagon Revenue 2019-2024 ($ Millions)
Figure 33. APAC Glucagon Sales 2019-2024 (K MT)
Figure 34. APAC Glucagon Revenue 2019-2024 ($ Millions)
Figure 35. Europe Glucagon Sales 2019-2024 (K MT)
Figure 36. Europe Glucagon Revenue 2019-2024 ($ Millions)
Figure 37. Middle East & Africa Glucagon Sales 2019-2024 (K MT)
Figure 38. Middle East & Africa Glucagon Revenue 2019-2024 ($ Millions)
Figure 39. Americas Glucagon Sales Market Share by Country in 2023
Figure 40. Americas Glucagon Revenue Market Share by Country in 2023
Figure 41. Americas Glucagon Sales Market Share by Type (2019-2024)
Figure 42. Americas Glucagon Sales Market Share by Application (2019-2024)
Figure 43. United States Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 44. Canada Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 45. Mexico Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 46. Brazil Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 47. APAC Glucagon Sales Market Share by Region in 2023
Figure 48. APAC Glucagon Revenue Market Share by Regions in 2023
Figure 49. APAC Glucagon Sales Market Share by Type (2019-2024)
Figure 50. APAC Glucagon Sales Market Share by Application (2019-2024)
Figure 51. China Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 52. Japan Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 53. South Korea Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 54. Southeast Asia Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 55. India Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 56. Australia Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 57. China Taiwan Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 58. Europe Glucagon Sales Market Share by Country in 2023
Figure 59. Europe Glucagon Revenue Market Share by Country in 2023
Figure 60. Europe Glucagon Sales Market Share by Type (2019-2024)
Figure 61. Europe Glucagon Sales Market Share by Application (2019-2024)
Figure 62. Germany Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 63. France Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 64. UK Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 65. Italy Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 66. Russia Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 67. Middle East & Africa Glucagon Sales Market Share by Country in 2023
Figure 68. Middle East & Africa Glucagon Revenue Market Share by Country in 2023
Figure 69. Middle East & Africa Glucagon Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Glucagon Sales Market Share by Application (2019-2024)
Figure 71. Egypt Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 72. South Africa Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 73. Israel Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 74. Turkey Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 75. GCC Country Glucagon Revenue Growth 2019-2024 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Glucagon in 2023
Figure 77. Manufacturing Process Analysis of Glucagon
Figure 78. Industry Chain Structure of Glucagon
Figure 79. Channels of Distribution
Figure 80. Global Glucagon Sales Market Forecast by Region (2025-2030)
Figure 81. Global Glucagon Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Glucagon Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Glucagon Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Glucagon Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Glucagon Revenue Market Share Forecast by Application (2025-2030)
